| Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, AM Bailey, L Strong, ... Annals of Oncology 27 (5), 795-800, 2016 | 187 | 2016 |
| Peripheral lung nodules: fluoroscopically guided video-assisted thoracoscopic resection after computed tomography-guided localization using platinum microcoils TI Powell, D Jangra, JC Clifton, H Lara-Guerra, N Church, J English, ... Annals of surgery 240 (3), 481-489, 2004 | 168 | 2004 |
| Phase II study of preoperative gefitinib in clinical stage I non–small-cell lung cancer H Lara-Guerra, TK Waddell, MA Salvarrey, AM Joshua, CT Chung, N Paul, ... Journal of Clinical Oncology 27 (36), 6229-6236, 2009 | 119 | 2009 |
| Comparison of computer-assisted instruction (CAI) versus traditional textbook methods for training in abdominal examination (Japanese experience) KY Qayumi AK, Kurihara Y, Imai M, Pachev G, Seo H, Hoshino Y, Cheifetz R ... Medical Education 38 (10), 1080-1088, 2004 | 105 | 2004 |
| The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation M Sato, S Hirayama, DM Hwang, H Lara-Guerra, D Wagnetz, TK Waddell, ... The Journal of Immunology 182 (11), 7307-7316, 2009 | 83 | 2009 |
| Tissue heterogeneity of EGFR mutation in lung adenocarcinoma A Sakurada, H Lara-Guerra, N Liu, FA Shepherd, MS Tsao Journal of Thoracic Oncology 3 (5), 527-529, 2008 | 82 | 2008 |
| Selected reaction monitoring (SRM) analysis of epidermal growth factor receptor (EGFR) in formalin fixed tumor tissue T Hembrough, S Thyparambil, WL Liao, MM Darfler, J Abdo, KM Bengali, ... Clinical proteomics 9, 1-10, 2012 | 73 | 2012 |
| The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform A Johnson, J Zeng, AM Bailey, V Holla, B Litzenburger, H Lara-Guerra, ... Drug discovery today 20 (12), 1433-1438, 2015 | 67 | 2015 |
| Histopathological and immunohistochemical features associated with clinical response to neoadjuvant gefitinib therapy in early stage non-small cell lung cancer H Lara-Guerra, CT Chung, J Schwock, M Pintilie, DM Hwang, NB Leighl, ... Lung cancer 76 (2), 235-241, 2012 | 51 | 2012 |
| MMP-dependent migration of extrapulmonary myofibroblast progenitors contributing to posttransplant airway fibrosis in the lung M Sato, S Hirayama, H Lara-Guerra, M Anraku, TK Waddell, M Liu, ... American Journal of Transplantation 9 (5), 1027-1036, 2009 | 48 | 2009 |
| Exogenous restoration of TUSC2 expression induces responsiveness to erlotinib in wildtype epidermal growth factor receptor (EGFR) lung cancer cells through context specific … B Dai, S Yan, H Lara-Guerra, H Kawashima, R Sakai, G Jayachandran, ... PloS one 10 (6), e0123967, 2015 | 33 | 2015 |
| Gene therapy for lung cancer H Lara-Guerra, JA Roth Critical Reviews™ in Oncogenesis 21 (1-2), 2016 | 30 | 2016 |
| CT-directed microcoil localization of small peripheral lung nodules: a feasibility study in pigs D Jangra, T Powell, SE Kalloger, HL Guerra, J Clifton, HO Coxson, ... Journal of Investigative Surgery 18 (5), 265-272, 2005 | 19 | 2005 |
| Cáncer de mama en mujeres jóvenes en México: necesidades y retos clínicos C Villarreal-Garza, C Águila, A Platas, H Lara-Guerra Revista de investigación clínica 66 (6), 547-558, 2014 | 17 | 2014 |
| Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature G Chen, J Zhao, T Cohen, C Tao, J Sun, H Xu, EV Bernstam, A Lawson, ... Database 2015, bav034, 2015 | 16 | 2015 |
| A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer AG Sacher, LW Le, H Lara-Guerra, TK Waddell, S Sakashita, Z Chen, ... Oncotarget 7 (18), 25632, 2016 | 13 | 2016 |
| Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case report S Campos-Gomez, H Lara-Guerra, MJ Routbort, X Lu, GR Simon The International Journal of Biological Markers 30 (2), 254-257, 2015 | 13 | 2015 |
| Prevalence of incidental actionable germline mutations in 1,000 advanced cancer patients on a prospective somatic genomic profiling program. F Meric-Bernstam, L Brusco, MS Daniels, LC Strong, KR Shaw, KH Lu, ... Journal of Clinical Oncology 33 (15_suppl), 1510-1510, 2015 | 8 | 2015 |
| Evaluación de la utilidad del pericardio bovino en resecciones pulmonares no anatómicas en perros JR Olmos-Zúñiga, R Jasso-Victoria, A Sotres-Vega, MO Gaxiola-Gaxiola, ... Rev. invest. clín, 334-341, 2002 | 8* | 2002 |
| Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy followed by … SK Jabbour, BC Cho, E Bria, T Kato, J Bhosle, JF Gainor, N Reguart, ... Journal of Clinical Oncology 39 (15_suppl), TPS8580-TPS8580, 2021 | 7 | 2021 |
TK WaddellDivision of Thoracic Surgery, University of Toronto在 uhn.ca 的电子邮件经过验证
